Top compounds associated with response to ADRA2A


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib gCSI pan-cancer AAC 0.078 0.2
mRNA MS-275 gCSI pan-cancer AAC -0.071 0.2
mRNA Irinotecan gCSI pan-cancer AAC -0.026 0.6
mRNA Bortezomib gCSI pan-cancer AAC 0.019 0.8
mRNA GDC-0941 gCSI pan-cancer AAC -0.015 0.8
mRNA Vorinostat gCSI pan-cancer AAC -0.00077 1
Download CSV